Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters








Publication year range
1.
FEBS Lett ; 587(10): 1579-86, 2013 May 21.
Article in English | MEDLINE | ID: mdl-23587483

ABSTRACT

Both radiotherapy and most effective chemotherapeutic agents induce different types of DNA damage. Here we show that tungstate modulates cell response to DNA damaging agents. Cells treated with tungstate were more sensitive to etoposide, phleomycin and ionizing radiation (IR), all of which induce DNA double-strand breaks (DSBs). Tungstate also modulated the activation of the central DSB signalling kinase, ATM, in response to these agents. These effects required the functionality of the Mre11-Nbs1-Rad50 (MRN) complex and were mimicked by the inhibition of PP2A phosphatase. Therefore, tungstate may have adjuvant activity when combined with DNA-damaging agents in the treatment of several malignancies.


Subject(s)
Cell Cycle Proteins/physiology , DNA Damage/drug effects , DNA-Binding Proteins/physiology , Protein Serine-Threonine Kinases/physiology , Tumor Suppressor Proteins/physiology , Tungsten Compounds/pharmacology , Animals , Ataxia Telangiectasia Mutated Proteins , Cell Cycle Proteins/metabolism , Cell Proliferation/drug effects , Cells, Cultured , DNA Breaks, Double-Stranded/drug effects , DNA Breaks, Double-Stranded/radiation effects , DNA Damage/genetics , DNA-Binding Proteins/metabolism , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , HEK293 Cells , HeLa Cells , Humans , Mice , Protein Serine-Threonine Kinases/metabolism , Radiation Dosage , Radiation, Ionizing , Signal Transduction/drug effects , Signal Transduction/genetics , Signal Transduction/radiation effects , Tumor Suppressor Proteins/metabolism
2.
FEBS Lett ; 586(3): 270-6, 2012 Feb 03.
Article in English | MEDLINE | ID: mdl-22245679

ABSTRACT

Tungstate counteracts diabetes and obesity in animal models, but its molecular mechanisms remain elusive. Our Saccharomyces cerevisiae-based approach has found that tungstate alleviated the growth defect induced by nutrient stress and enhanced the activation of the GCN pathway. Tungstate relieved the sensitivity to starvation of a gcn2-507 yeast hypomorphic mutant, indicating that tungstate modulated the GCN pathway downstream of Gcn2p. Interestingly, tungstate inhibited Glc7p and PP1 phosphatase activity, both negative regulators of the GCN pathway in yeast and humans, respectively. Accordingly, overexpression of a dominant-negative Glc7p mutant in yeast mimicked tungstate effects. Therefore tungstate alleviates nutrient stress in yeast by in vivo inhibition of Glc7p. These data uncover a potential role for tungstate in the treatment of PP1 and GCN related diseases.


Subject(s)
Anti-Obesity Agents/pharmacology , Antineoplastic Agents/pharmacology , Hypoglycemic Agents/pharmacology , Protein Phosphatase 1/antagonists & inhibitors , Saccharomyces cerevisiae Proteins/antagonists & inhibitors , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/metabolism , Tungsten Compounds/pharmacology , Amino Acids/deficiency , Drug Synergism , Food , Humans , Mutation , Protein Serine-Threonine Kinases/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae Proteins/genetics , Tacrolimus/pharmacology , Triazoles/chemistry , Triazoles/pharmacology
3.
Cancer Lett ; 273(2): 281-91, 2009 Jan 18.
Article in English | MEDLINE | ID: mdl-18818012

ABSTRACT

Radio and chemotherapy are the election options besides surgical resection, in cancer treatment. However, resistance to chemotherapy limits the effectiveness of therapy in the clinic. An improved knowledge of the mechanisms underlying the resistance to treatment would generate new therapeutic strategies. Genetic suppressor elements (GSEs) are short, biologically active, cDNA fragments that interfere with the function of their cognate gene. By selection of genetic suppressor elements (GSEs) conferring resistance to cisplatin, we identified the GSE11, that corresponds to the hCCR4/CNOT6 gene that mediates cellular sensitivity to the drug. Expression of GSE11-hCCR4 reduces hCCR4 protein levels in cells. Targeting hCCR4 with GSE11 or with siRNA, decreases sensitivity of mammalian cells to DNA-damaging agents. Overexpression of hCCR4 targets Chk2 following exposure to cisplatin, without interfering with the upstream ATM/ATR pathway, however histone gammaH2AX is strongly phosphorylated in these cells compared to control cells. Our results uncover a new function for a human protein involved in chemotherapy response. This finding introduces a new pharmacological target in the treatment of solid tumours.


Subject(s)
DNA Damage , Exoribonucleases/metabolism , Histones/genetics , Animals , Antineoplastic Agents/pharmacology , Cell Survival , Cisplatin/pharmacology , Exoribonucleases/genetics , Gene Library , Humans , Mice , Microscopy, Fluorescence , Phosphorylation , RNA, Small Interfering/metabolism , Response Elements
4.
Clin Transl Oncol ; 9(4): 221-8, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17462974

ABSTRACT

The budding yeast Saccharomyces cerevisiae is being widely used as a model for investigating fundamental processes relevant to all living organisms. Many of these processes are affected by genetic and epigenetic alterations in cancer such as cell cycle progression, DNA replication and segregation, maintenance of genomic integrity and stress responses. Therefore, yeast emerges as an attractive model for anticancer drug research. The genetic tractability of budding yeast, its ease of manipulation and the wealth of functional genomics tools available in this organism makes it ideal for genome-wide analysis of biological functions and chemical screenings. The present review will discuss some of the innovative advantages based on yeast genetics and genomics for antitumour drug target identification and drug discovery.


Subject(s)
Antineoplastic Agents , Drug Design , Drug Screening Assays, Antitumor/methods , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/genetics , Antineoplastic Agents/pharmacology , DNA, Complementary/genetics , Drug Resistance, Fungal , Gene Deletion , Gene Expression Profiling , Gene Expression Regulation, Fungal , Genes, Fungal , Genetic Research , Genomics/methods , Humans , Mutation , Oligonucleotide Array Sequence Analysis , Proteomics/methods
5.
Cell Mol Life Sci ; 61(6): 700-8, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15052412

ABSTRACT

The immunosuppressants tacrolimus (FK506) and cyclosporin A (CsA) have increased the survival rates in organ transplantation. Both drugs inhibit the protein phosphatase calcineurin (CaN) in activated T cells, exhibiting similar side-effects. Diabetes is observed more often in FK506 than CsA therapy, probably due to inhibition of new molecular targets other than CaN. We studied FK506 toxicity in mammalian cells. FK506, but not CsA, regulated p38 activation by osmotic stress, and decreased viability in osmostressed cells. In addition, FK506 treatment strongly increased the phosphorylation of the eukaryotic initiation factor-2alpha (eIF-2alpha) subunit. eIF-2alpha phosphorylation, p38 inhibition and cell lethality were relieved by addition of excess amino acids to the medium, suggesting that amino acid availability mediated FK506 toxicity. Therefore, these FK506-dependent responses could be relevant to the non-therapeutic effects of FK506 therapy.


Subject(s)
Immunosuppressive Agents/pharmacology , Kidney/drug effects , Mitogen-Activated Protein Kinases/metabolism , Tacrolimus/pharmacology , Calcineurin/metabolism , Calcineurin/pharmacology , Cell Death/drug effects , Cells, Cultured , Cyclosporine/pharmacology , Enzyme Activation , Eukaryotic Initiation Factor-2/metabolism , Humans , Kidney/cytology , Kidney/enzymology , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Osmolar Concentration , Phosphorylation/drug effects , Saccharomyces cerevisiae , Saccharomyces cerevisiae Proteins/metabolism , Signal Transduction/drug effects , Sorbitol/pharmacology , Tryptophan/metabolism , p38 Mitogen-Activated Protein Kinases
6.
J Nat Prod ; 66(5): 722-4, 2003 May.
Article in English | MEDLINE | ID: mdl-12762819

ABSTRACT

The aerial parts of Nanodea muscosa, collected in Chile, yielded two new acetylenic acids. Their structures were elucidated by spectroscopic analyses, including 2D NMR techniques, as (13E)-octadec-13-en-11-ynoic acid (1) and (2E)-octadec-2-en-4-ynedioic acid (2). Compound 2 constitutes the first example of a conjugated ene-yne fatty diacid isolated from a natural source. Compounds 1 and 2 did not exhibit toxicity toward a panel of DNA damage checkpoint defective yeast mutants or show affinity for the 5-HT(1A), 5-HT(2A), D(2), and H(1) receptors.


Subject(s)
Fatty Acids, Unsaturated/isolation & purification , Santalaceae/chemistry , Alkynes , Chile , DNA Damage/drug effects , Fatty Acids, Unsaturated/chemistry , Fatty Acids, Unsaturated/pharmacology , Molecular Structure , Receptor, Serotonin, 5-HT2A , Receptors, Dopamine D2/drug effects , Receptors, Histamine H1/drug effects , Receptors, Serotonin/drug effects , Receptors, Serotonin, 5-HT1 , Saccharomyces cerevisiae/drug effects , Stereoisomerism
7.
Curr Opin Genet Dev ; 10(1): 17-25, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10679395

ABSTRACT

DNA damage or stalled DNA replication can activate specific signal transduction pathways, termed checkpoints. Checkpoint activation can result in increased repair, induction of a transcriptional programme and inhibition of cell-cycle progression. Recent results have suggested possible mechanisms for the detection of specific DNA structures, provided further information on the organisation of the signal transduction cascade and demonstrated involvement of the checkpoint pathway in DNA repair.


Subject(s)
DNA Damage , Genes, cdc , Signal Transduction , Animals , Apoptosis , Cell Cycle , DNA Damage/genetics , DNA Damage/physiology , DNA Repair , Humans , Yeasts
8.
Genes Dev ; 12(16): 2560-73, 1998 Aug 15.
Article in English | MEDLINE | ID: mdl-9716408

ABSTRACT

Preventing or delaying progress through the cell cycle in response to DNA damage is crucial for eukaryotic cells to allow the damage to be repaired and not incorporated irrevocably into daughter cells. Several genes involved in this process have been discovered in fission and budding yeast. Here, we report the identification of human and mouse homologs of the Schizosaccharomyces pombe DNA damage checkpoint control gene rad1(+) and its Saccharomyces cerevisiae homolog RAD17. The human gene HRAD1 is located on chromosome 5p13 and is most homologous to S. pombe rad1(+). This gene encodes a 382-amino-acid residue protein that is localized mainly in the nucleus and is expressed at high levels in proliferative tissues. This human gene significantly complements the sensitivity to UV light of a S. pombe strain mutated in rad1(+). Moreover, HRAD1 complements the checkpoint control defect of this strain after UV exposure. In addition to functioning in DNA repair checkpoints, S. cerevisiae RAD17 plays a role during meiosis to prevent progress through prophase I when recombination is interrupted. Consistent with a similar role in mammals, Rad1 protein is abundant in testis, and is associated with both synapsed and unsynapsed chromosomes during meiotic prophase I of spermatogenesis, with a staining pattern distinct from that of the recombination proteins Rad51 and Dmc1. Together, these data imply an important role for hRad1 both in the mitotic DNA damage checkpoint and in meiotic checkpoint mechanisms, and suggest that these events are highly conserved from yeast to humans.


Subject(s)
DNA-Binding Proteins , Exonucleases/physiology , Meiosis/physiology , Amino Acid Sequence , Animals , Cell Cycle/physiology , Cell Cycle Proteins/chemistry , Cell Nucleus/metabolism , Chromosome Mapping , DNA Damage , DNA Repair , DNA Repair Enzymes , Endonucleases/chemistry , Fungal Proteins/chemistry , Gene Expression , Genetic Complementation Test , HeLa Cells , Humans , Male , Meiosis/genetics , Mice , Molecular Sequence Data , Mutation , Nuclear Proteins , Prophase , Rats , Saccharomyces cerevisiae/chemistry , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins , Schizosaccharomyces/chemistry , Schizosaccharomyces/genetics , Schizosaccharomyces pombe Proteins , Sequence Homology, Amino Acid , Spermatogenesis/genetics , Spermatogenesis/physiology , Testis/cytology , Testis/physiology , Up-Regulation
9.
Oncogene ; 16(4): 533-40, 1998 Jan 29.
Article in English | MEDLINE | ID: mdl-9484843

ABSTRACT

Genotoxic stress triggers signalling pathways that either mediate cell killing or protection of affected cells. While induction of p53 is observed for most of the genotoxins, activation of MAPK/SAPK cascades is not a general response. The role of MAPK/SAPK activation on cell fate, seems to be dependent, in some systems, on the balanced response among both cascades. We have here examined the effect of cis and trans-DDP on the activation of ERK and JNK activities. While no significant induction of ERK was observed with the compounds, both of them are able to strongly activate JNK. Trans-DDP response is rapid and transient while the cis-DDP one is slow and persistent. In contrast with the observed nuclear translocation of JNK in response to U.V. light, none of the platinum compounds induces translocation, on the contrary, activation of JNK occurs in both the nuclear and cytoplasmic compartments. Inhibition of tyrosine phosphatases by orthovanadate pretreatment prolongs the time of JNK induction in response to both platinum compounds. The positive modulation of JNK activation correlates with an increase in toxicity that, for cis-DDP corresponds to a tenfold decrease in the IC50. A strong increase in MKP-1 levels was observed only in response to trans-DDP suggesting the involvement of this activity in the downregulation of JNK activity in response to this compound. Altogether the results suggest that the prolonged activation of JNK in response to cis-DDP contributes to cell death induction.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cisplatin/pharmacology , DNA Damage , Mitogen-Activated Protein Kinases , Animals , Cell Line/drug effects , Cell Line/enzymology , Cell Nucleus/enzymology , Cytoplasm/enzymology , Enzyme Activation/drug effects , JNK Mitogen-Activated Protein Kinases , Mice , Vanadates/pharmacology
10.
J Biol Chem ; 271(46): 29029-33, 1996 Nov 15.
Article in English | MEDLINE | ID: mdl-8910555

ABSTRACT

The yeast halotolerance gene HAL2 encodes a nucleotidase that dephosphorylates 3'-phosphoadenosine 5'-phosphate (PAP) and 3'-phosphoadenosine 5'-phosphosulfate (PAPS), intermediates of the sulfate assimilation pathway. This nucleotidase is inhibited by Na+ and Li+ but not by K+. Incubation of wild-type yeast cells with NaCl and LiCl, but not with KCl, increased intracellular PAP to millimolar concentrations. No depletion of the pool of adenine nucleotides (AMP, ADP, ATP) was observed. Other stresses such as heat shock or oxidative stress did not result in PAP accumulation. PAPS concentrations also increased during salt stress but remained lower than 0.5 microM. S-Adenosylmethionine concentrations decreased by 50%, reflecting inhibition of sulfate assimilation during salt stress. Salt-induced PAP accumulation was attenuated in a yeast strain overexpressing HAL2. This strain grew better than the wild type under salt stress. These results suggest that the cation sensitivity of the HAL2 nucleotidase is an important determinant of the inhibition of yeast growth by sodium and lithium salts. In addition to blocking sulfate assimilation by product inhibition of PAPS reductase, PAP accumulation may have other unidentified toxic effects.


Subject(s)
Fungal Proteins/metabolism , Lithium Chloride/toxicity , Nucleotidases/metabolism , Lithium Chloride/metabolism , Methionine/biosynthesis , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/metabolism , Substrate Specificity , Sulfates/metabolism
11.
J Cell Biochem ; 57(4): 630-40, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7615647

ABSTRACT

Changes in intracellular pH (pHin) take part in the mitogenic response. Their importance has been stressed by the finding that mouse fibroblasts expressing a yeast proton pumping ATPase (PMA1) exhibit a transformed phenotype and are tumorigenic. These cells do maintain a higher pHin, supporting the idea that elevated pHin may act as a proliferative trigger. Here we show that cells constitutively expressing PMA1 have higher levels of the AP-1 transcription factor. The use of stable transfectants and transient transfection assays show that PMA1 activity induces transactivation of the c-fos promoter. The activation of the promoter is mediated throughout the serum response element (SRE). The use of protein kinase C inhibitors suggests that AP-1 activation is achieved through a pathway independent of protein kinase C.


Subject(s)
Endopeptidases , Genes, fos , Oncogene Proteins , Promoter Regions, Genetic , Proton Pumps/drug effects , Transcriptional Activation/drug effects , 3T3 Cells , Adenosine Triphosphatases/biosynthesis , Adenosine Triphosphatases/genetics , Animals , Base Sequence , Cattle , Colforsin/pharmacology , Culture Media , Cyclic AMP-Dependent Protein Kinases/metabolism , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , Electrophoresis , Hydrogen-Ion Concentration , Mice , Molecular Sequence Data , Nuclear Proteins/biosynthesis , Nuclear Proteins/genetics , Oncogene Proteins, Fusion/biosynthesis , Oncogene Proteins, Fusion/genetics , Protein Kinase C/metabolism , Protein Kinase Inhibitors , Proto-Oncogene Proteins , Serum Response Factor , Tissue Plasminogen Activator/pharmacology , Transcription Factor AP-1/biosynthesis , Transcription Factor AP-1/genetics , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transfection , Ubiquitin Thiolesterase
12.
J Gen Virol ; 76 ( Pt 4): 729-40, 1995 Apr.
Article in English | MEDLINE | ID: mdl-9049318

ABSTRACT

A group of cross-hybridizing DNA segments contained within the EcoRI restriction fragments U', X and J of a Vero cell-adapted strain (BA71V) of African swine fever virus (ASFV) were mapped and sequenced. Analysis of the nucleotide sequence revealed the presence of a set of long internal repeated sequences composed of five types of tandemly repeat units of about 200 bp. These tandem repeats contain a G-rich core of 10-14 nucleotides surrounded by regions with a high A + T content distributed in oligo(dA).oligo(dT) tracts. Next to the repeated sequences we detected two related open reading frames that are members of a new multigene family (multigene family 300). Comparison of DNA sequences from several virus isolates indicated that this region undergoes frequent rearrangements leading to either duplications or deletions of the repeat units. These ASFV repeated sequences share similarities with chromosomal alpha satellite DNA, the scaffold-associated region and satellite III of Drosophila. Similar tandemly repeated sequences have not been described in other viruses.


Subject(s)
African Swine Fever Virus/genetics , DNA, Viral/analysis , Repetitive Sequences, Nucleic Acid , African Swine Fever Virus/isolation & purification , Amino Acid Sequence , Animals , Base Sequence , Blotting, Southern , Chlorocebus aethiops , Chromosome Mapping , Deoxyribonuclease EcoRI/metabolism , Deoxyribonuclease HindIII/metabolism , Molecular Sequence Data , Open Reading Frames , Transcription, Genetic , Vero Cells
13.
Science ; 267(5195): 232-4, 1995 Jan 13.
Article in English | MEDLINE | ID: mdl-7809627

ABSTRACT

Overexpression of a yeast gene, HAL2, allows the cells to tolerate higher than normal extracellular salt concentrations. HAL2 encodes a 3'(2')5'-bisphosphate nucleotidase that serves to remove the end products of sulfate transfer during cellular metabolism. The enzyme is inhibited by lithium and sodium and is activated by potassium. Metabolic systems that are sensitive to salt, as well as those governing osmolyte synthesis and ion transport, offer routes by which genetic engineering can be used to improve the tolerance of various organisms to salt.


Subject(s)
Fungal Proteins/metabolism , Lithium/pharmacology , Nucleotidases/metabolism , Saccharomyces cerevisiae/enzymology , Sodium/pharmacology , Sulfates/metabolism , Adenosine Diphosphate/metabolism , Adenosine Monophosphate/metabolism , Enzyme Activation , Fungal Proteins/antagonists & inhibitors , Fungal Proteins/genetics , Nucleotidases/antagonists & inhibitors , Nucleotidases/genetics , Potassium/pharmacology , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/genetics
SELECTION OF CITATIONS
SEARCH DETAIL